Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001516551-21-000027
Filing Date
2021-12-16
Accepted
2021-12-16 18:59:38
Documents
1
Period of Report
2021-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163969915831608.html 4  
1 FORM 4 wf-form4_163969915831608.xml 4 5772
  Complete submission text file 0001516551-21-000027.txt   7477
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5910 PACIFIC CENTER BLVD, SUITE 320 C/O SKYE BIOSCIENCE, INC. SAN DIEGO CA 92121
Business Address
Arsenault Kaitlyn Melanie (Reporting) CIK: 0001877242 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55136 | Film No.: 211499140